LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Drug Pipeline Amphista Therapeutics is actively developing next-generation targeted protein degradation medicines, including clinical candidates like AMX-883 for BRD9 and SMARCA2 degraders for NSCLC, indicating potential opportunities to collaborate on cutting-edge oncological treatments.

Strategic Industry Presence The company regularly participates in high-profile scientific and industry events such as AACR and ASH, showcasing its advanced research and creating opportunities to connect with biotech and pharmaceutical partners interested in novel TPD technologies.

Recent Leadership Expansion The appointment of a new CEO and Chief Medical Officer demonstrates a focus on strategic growth and clinical development, providing avenues to align with the company's expanding leadership and explore partnership opportunities.

Focused Biotech Market With a specialized focus on targeted protein degradation and a relatively small team, Amphista is positioned as an agile partner for biotech firms seeking innovative drug discovery solutions in the growing TPD landscape.

Funding and Revenue Potential Although current revenue is modest, ongoing clinical advancements and participation in prominent industry forums suggest potential for future growth and investment opportunities, especially in collaborations for novel therapeutics and platform expansion.

Amphista Therapeutics Limited Tech Stack

Amphista Therapeutics Limited uses 8 technology products and services including Unpkg, Cloudflare, Module Federation, and more. Explore Amphista Therapeutics Limited's tech stack below.

  • Unpkg
    Content Delivery Network
  • Cloudflare
    Content Management System
  • Module Federation
    Development
  • JSON-LD
    Javascript Frameworks
  • Lenis
    Javascript Libraries
  • Floating UI
    Javascript Libraries
  • JavaScript
    Programming Languages
  • Cloudflare Bot Management
    Security

Media & News

Amphista Therapeutics Limited's Email Address Formats

Amphista Therapeutics Limited uses at least 1 format(s):
Amphista Therapeutics Limited Email FormatsExamplePercentage
First@amphista.comJohn@amphista.com
42%
First.Last@amphista.comJohn.Doe@amphista.com
8%
First@amphista.comJohn@amphista.com
42%
First.Last@amphista.comJohn.Doe@amphista.com
8%

Frequently Asked Questions

Where is Amphista Therapeutics Limited's headquarters located?

Minus sign iconPlus sign iconAmphista Therapeutics Limited's main headquarters is located at Great Abington, England cb21 6gq United Kingdom. The company has employees across 2 continents, including EuropeNorth America.

What is Amphista Therapeutics Limited's official website and social media links?

Minus sign iconPlus sign iconAmphista Therapeutics Limited's official website is amphista.com and has social profiles on LinkedInCrunchbase.

What is Amphista Therapeutics Limited's SIC code NAICS code?

Minus sign iconPlus sign iconAmphista Therapeutics Limited's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Amphista Therapeutics Limited have currently?

Minus sign iconPlus sign iconAs of March 2026, Amphista Therapeutics Limited has approximately 62 employees across 2 continents, including EuropeNorth America. Key team members include Chief Executive Officer: A. M.Chief Scientific Officer: L. M.Chief Development Officer: M. P.. Explore Amphista Therapeutics Limited's employee directory with LeadIQ.

What industry does Amphista Therapeutics Limited belong to?

Minus sign iconPlus sign iconAmphista Therapeutics Limited operates in the Biotechnology Research industry.

What technology does Amphista Therapeutics Limited use?

Minus sign iconPlus sign iconAmphista Therapeutics Limited's tech stack includes UnpkgCloudflareModule FederationJSON-LDLenisFloating UIJavaScriptCloudflare Bot Management.

What is Amphista Therapeutics Limited's email format?

Minus sign iconPlus sign iconAmphista Therapeutics Limited's email format typically follows the pattern of First@amphista.com. Find more Amphista Therapeutics Limited email formats with LeadIQ.

When was Amphista Therapeutics Limited founded?

Minus sign iconPlus sign iconAmphista Therapeutics Limited was founded in 2017.

Amphista Therapeutics Limited

Biotechnology ResearchEngland, United Kingdom51-200 Employees

At Amphista Therapeutics we are developing drugs to bring life-changing medicines to patients. Powered by transformational science we are advancing beyond traditional degrader approaches, addressing limitations associated with the use of a narrow range of protein degrading mechanisms.

Amphista Therapeutics is an exciting spin out company founded by Advent Life Sciences and built on groundbreaking science from the laboratory of Professor Alessio Ciulli (University of Dundee), a world leader in the field of targeted protein degradation.

Targeted protein degradation (TPD) hijacks the cell’s degradation machinery to modulate abundance of proteins that are responsible for disease progression. Our approach to protein degradation differentiates from traditional TPD technologies and is being developed to treat diseases with high unmet need.

Section iconCompany Overview

Headquarters
Great Abington, England cb21 6gq United Kingdom
Website
amphista.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $1M$10M

    Amphista Therapeutics Limited's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Amphista Therapeutics Limited's revenue is estimated to be in the range of $1M$10M

Company Leadership

  • Stylized image of a person
    A. M.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. M.
    Chief Scientific Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. P.
    Chief Development Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. S.
    Vp Translational Science
    Phone icon
    Mobile Phone
  • Stylized image of a person
    O. A.
    Head Of Contracts
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    A. S.
    Vp Translational Science
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. H. B.
    Senior Vice President Clinical Operations
    Phone icon
    Mobile Phone
  • Stylized image of a person
    O. A.
    Head Of Contracts
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. S.
    Non Executive Director
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. L.
    Senior Director Of Oncology
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.